Last reviewed · How we verify
NCT04960735: VOICE
Implementation, Effectiveness and Impact of a Value Based Intervention for Patients with Breast or Lung Cancer
NA trial testing VOICE intervention in Breast Cancer in 1,007 participants. Completed in 30 March 2023.
31 December 2020
Quick facts
| Lead sponsor | Biosistemak Institute for Health Systems Research |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | health services research |
| Enrollment | 1,007 |
| Start date | 1 January 2019 |
| Primary completion | 31 December 2020 |
| Estimated completion | 30 March 2023 |
| Sites | 8 locations across France, Italy, Belgium, Portugal, Spain |
Drugs / interventions tested
- VOICE intervention
Conditions studied
- Breast Cancer — all drugs for Breast Cancer →
- Lung Cancer — all drugs for Lung Cancer →
Sponsor
Biosistemak Institute for Health Systems Research
Who can join
18 and older, any sex, with Breast Cancer or Lung Cancer. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
VOICE project aims to guide health services in their reorganization towards the provision of the highest value care for the patient at the best cost. VOICE is targeted to patients with breast and lung cancer. The purpose is to offer a new innovative strategic framework based on value-based healthcare model to these patients in Europe. VOICE Community consists of 13 hospitals across Europe working collaboratively to implement this approach. The Community addresses what matters most to patients by measuring patient reported health outcomes in routine clinical practice on a systematic and long-term basis, by including patients´ perspective in clinical decision-making, improving patient empowerment and physician-patient communication, assessing the impact on costs of the processes implemented, identifying factors for a successful implementation of value-based healthcare and boosting knowledge generation and best practice exchange across Europe. The VOICE ambition is to collect the health-related Quality of Life evidence from more than 1000 patients (patients with breast cancer and patients with lung cancer), by means of health related and patient reported questionnaires (ICHOM, International Consortium for Health Outcome Measurements, standard sets). Hospitals will go further by assessing the satisfaction, acceptability, relationship with professionals or decision-making process with patients. The VOICE Community will benchmark health outcomes and related costs to improve care delivery of these patients.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Basing healthcare decisions on value: patient-reported outcomes for patients diagnosed with breast cancer in a European cohort.
Gorostiza A, Cacicedo J, Alayo I, Frias A, et al · · 2025 · cited 1× · PMID 40614331 · DOI 10.1093/eurpub/ckaf064
Verify or expand the search:
- PubMed search for NCT04960735
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Breast Cancer
Currently open trials in the same condition.
- NCT06148038 — CBD for Breast Cancer Primary Tumors · Phase 1 · recruiting
- NCT07405801 — A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus R · Phase 2 · recruiting
- NCT07285993 — Detection and Outcomes in Metastatic Invasive Lobular Breast Cancer Through Novel F-18 FAP PET · Phase 2 · recruiting
- NCT07510698 — Same-Day Awake Mastectomy With Immediate Breast Reconstruction for Patients With Breast Cancer · NA · recruiting
- NCT06768931 — Biolosion Combined Standard Neoadjuvant Therapy to Treat Triple-negative Breast Cancer · Phase 2 · recruiting
Other Biosistemak Institute for Health Systems Research trials
Trials by the same sponsor.
- NCT05575336 — Assessment of the Effectiveness, Socio-economic Impact and Implementation of a Digital Solution for Severe Patients · NA · completed
- NCT05614479 — Health Promotion Community-based Intervention Among Elderly People Through Self-managed MAHA Mobile App. · NA · unknown
- NCT03951376 — Universal Preventive Resilience Intervention to Improve and Promote Mental Health for Teenagers · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04960735 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Biosistemak Institute for Health Systems Research
- Last refreshed: 10 March 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04960735.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing